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DYRK1A is the human orthologue of the Drosophila minibrain (mnb) gene, which is involved in postembryonic
neurogenesis in flies. Because of its mapping position on chromosome 21 and the neurobehavioral alterations
shown by mice overexpressing this gene, involvement of DYRK1A in some of the neurological defects of Down
syndrome patients has been suggested. To gain insight into its physiological role, we have generated mice
deficient in Dyrk1A function by gene targeting. Dyrk1A/ null mutants presented a general growth delay and
died during midgestation. Mice heterozygous for the mutation (Dyrk1A/) showed decreased neonatal
viability and a significant body size reduction from birth to adulthood. General neurobehavioral analysis
revealed preweaning developmental delay of Dyrk1A/ mice and specific alterations in adults. Brains of
Dyrk1A/ mice were decreased in size in a region-specific manner, although the cytoarchitecture and
neuronal components in most areas were not altered. Cell counts showed increased neuronal densities in some
brain regions and a specific decrease in the number of neurons in the superior colliculus, which exhibited a
significant size reduction. These data provide evidence about the nonredundant, vital role of Dyrk1A and
suggest a conserved mode of action that determines normal growth and brain size in both mice and flies.
Dual-specificity tyrosine-regulated kinases (DYRKs) are a
novel subfamily of protein kinases that catalyze their autophos-
phorylation on tyrosine residues and the phosphorylation of
serine/threonine residues on exogenous substrates (5, 7, 19).
Their kinase activity depends on the presence of a YXY motif
in the activation loop of the catalytic domain (20), which is
located at the same position as the characteristic TXY motif of
the mitogen-activated protein kinases (MAPKs), indicating a
possible involvement of these proteins in signal transduction
pathways similar to those of the MAPKs (26).
Lower eukaryotic members of this family are the kinases
Yak1p in Saccharomyces cerevisiae (13), Pom1p in Schizosac-
charomyces pombe (4), and YakA in Dictyostelium discoideum
(33). Although strains with mutations in these proteins present
different phenotypic abnormalities, they all seem to be in-
volved in cell cycle regulation and the control of the cell tran-
sition from growth to differentiation. The DYRK protein of
Drosophila melanogaster, called minibrain (mnb), is implicated
in postembryonic neurogenesis. Mutant flies with reduced mnb
expression present reductions in the volumes of the adult optic
lobes and central brain hemispheres, due to abnormal spacing
of neuroblasts in the outer proliferation center of the larval
brain (34). Mammalian DYRKs include DYRK1A, DYRK1B
(or MIRK), DYRK2, DYRK3, and DYRK4 (6). DYRK1A is
the most extensively characterized member of this family, and
it shares all the characteristic motifs of the catalytic domain
with the other family members. Outside the catalytic domain it
presents some special features, such as a bipartite nuclear
localization signal, a PEST sequence, a histidine repeat, and a
region rich in serine-threonine residues (20).
The human DYRK1A gene maps to chromosome 21
(HSA21) in the Down syndrome (DS) critical region 21q22.2
(16, 29, 32). Part of this region includes the chromosomal
segment deleted in HSA21-linked microcephaly (24). The
mouse Dyrk1A gene maps to chromosome 16, in the region of
synteny with HSA21 (31). The human DYRK1A and rodent
Dyrk1A genes are ubiquitously expressed in tissues of adult and
fetal origin (16, 32), with high expression levels in the brain and
heart during development (27). In addition, DYRK1A is over-
expressed in DS fetal brains, while its mouse orthologue is
overexpressed in the brains of adult Ts65Dn mice (15), a par-
tial trisomy 16 mouse model, widely used as a model for DS
(11). All these data suggest that DYRK1A might be one of the
genes involved in some of the neurological abnormalities ob-
served in DS patients. In agreement with this is the fact that
transgenic mouse models overexpressing the Dyrk1A gene
present a deficit in visuospatial learning and memory (3, 30).
DYRK1A phosphorylates a variety of substrates in vitro,
such as the signal transducer and activator of transcription 3
(STAT3) (25), the ε subunit of eukaryotic initiation factor 2B
(eIF2Bε), the microtubule-associated protein tau (35), and the
transcription factor of the forkhead family FKHR (36), indi-
cating its possible involvement in more than one biochemical
pathway in vivo. The only available data about its in vivo role
show that DYRK1A, when activated by the basic fibroblast
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growth factor (bFGF) in immortalized hippocampal progeni-
tor cells, stimulates the phosphorylation of the cyclic AMP
response element binding protein (CREB) and induces subse-
quent CRE-mediated gene transcription. In addition, overex-
pression of a kinase-deficient DYRK1A remarkably attenuates
the differentiation of hippocampal cells (37). Although the
exact role of DYRK1A in central nervous system (CNS) func-
tion has not been determined, this recent finding provides the
first evidence about the involvement of DYRK1A in neuronal
differentiation.
To contribute to the elucidation of the physiological func-
tion of DYRK1A, we have performed targeted disruption of
the Dyrk1A gene in mice. The phenotypic effects of the loss of
one and two copies of Dyrk1A are presented, providing evi-
dence about the role of DYRK1A in normal growth, develop-
ment, and CNS function.
MATERIALS AND METHODS
Targeted disruption of Dyrk1A. A 15.5-kb clone was isolated from a lambda
FIXII genomic library (129 SVJ; Stratagene) by using as a probe a PCR fragment
that expands 979 nucleotides (nucleotides 786 to 1768; accession number
AF108830) of the human DYRK1A cDNA. The insert was mapped and partially
sequenced to determine the intron-exon boundaries. The exons contained in the
phage clone correspond to exons 5 to 8 of the human gene (15). To construct the
targeting vector, a 5-homology arm of 3.6 kb containing exon 6, a 3-homology
arm of 2.1 kb containing the 3 end of exon 8, the PGKneobpA cassette, and the
PGKtk cassette were subcloned in several steps into the pSP72 plasmid (Pro-
mega). The resulting construct was linearized at the unique PvuI site and elec-
troporated into E14-1 cells as previously described (21). Clones resistant to G418
and ganciclovir were analyzed by Southern blotting using EcoRI-digested DNA
and a 5-flanking probe (see Fig. 1). Two correctly recombinant clones (clones 13
and 40) were microinjected into C57BL/6 blastocysts, resulting in male chimeras
that were subsequently bred with C57BL/6 females to generate heterozygous
offspring. Although the two lines showed identical phenotypes, the data pre-
sented were obtained from mice derived from embryonic stem (ES) cell clone 13
on a mixed C57BL/6–129Ola genetic background.
Genotyping mice and embryos. Mice and embryos were genotyped by South-
ern blotting as shown in Fig. 1C or by PCR analysis by using tail or yolk sac
genomic DNA. A combination of the neo primer P1 (5-ATTCGCAGCGCAT
CGCCTTCTATCGCC-3) and the Dyrk1A primers P2 (5CTTATGACAGAG
TGGAGCAA-3) and P3 (5-CGTGATGAGCCCTTACCTATG-3) (see Fig.
1B) was used to amplify the wild-type and mutant alleles. PCR comprised
denaturation at 96°C for 3 min, followed by 35 cycles of 30 s at 94°C, 35 s at 60°C,
and 40 s at 72°C, and a final extension step at 74°C for 10 min.
Reverse transcription-PCR (RT-PCR). Total RNA was isolated from wild-
type and Dyrk1A/ brains by using the Tripure RNA extraction reagent
(Roche). Samples (1 g) were reverse transcribed with a random hexamer
primer (Pharmacia) and SuperScript II (Invitrogen) by following the manufac-
turer’s conditions. Dyrk1A primers P4 (5-GAGAGACTTCAGCATGCA-3)
and P5 (5-CCAACTGACAAGAGCTGCCA-3) were used for PCR amplifica-
tion.
Western blot analysis. Proteins were extracted by homogenizing mouse em-
bryos at day 10.5 of gestation (E10.5) in boiling 2 sodium dodecyl sulfate (SDS)
sample buffer (22) and separated in an SDS–7.5% PAGE gel. The amount of
protein loaded in the gel was standardized by Coomassie brilliant blue staining
by using proteins of known concentrations as controls. Proteins were transferred
to nitrocellulose membranes (Amersham), and successful transfer was controlled
by Ponceau S staining. Membranes were blocked with 5% low-fat milk in phos-
phate-buffered saline (PBS). Incubations with primary antibodies were carried
out in PBS with 3% low-fat milk. Primary antibodies were detected with horse-
radish peroxidase-conjugated antibodies, and positive signals were visualized
with the ECL system (Pierce). As primary antibodies we used a mouse polyclonal
antibody raised in our laboratory against the last 144 amino acids of rat Dyrk1A
(dilution, 1:250) and a goat polyclonal antibody against the amino terminus of
Dyrk1A (G-19; sc-12568; dilution, 1:100; Santa Cruz Biotechnology).
Embryo histology, immunohistochemistry, and in situ hybridization.
Dyrk1A/ mice were mated, and the morning of the vaginal plug was defined
as embryonic day 0.5 (E0.5). A minimum of two embryos of each genotype
(Dyrk1A/, Dyrk1A/, and Dyrk1A/) from at least two litters were col-
lected at E9.5, E10.5, and E11.5 and fixed in 4% paraformaldehyde in PBS for
24 h at 4°C. Embryos were dehydrated in an ethanol series, cleared in xylene, and
embedded in paraffin. Paraffin blocks were serially sectioned (thickness, 10 m)
and stained with cresyl violet. Sections were carefully examined to detect histo-
logical differences between wild-type, Dyrk1A/, and Dyrk1A/ embryos.
Immunohistochemistry was performed after blocking of endogenous peroxidase
with 0.03% H2O2 solution in PBS for 20 min at 4°C. After three rinses with PBS,
sections were washed with four consecutive changes of a solution of 0.1% Triton
X-100 in PBS for 10 min each time. Sections were blocked for an hour in blocking
solution (0.2% gelatin, 10% normal goat serum, and 0.1% Triton X-100 in PBS)
and incubated overnight at 4°C with a monoclonal antibody against -tubulin
(Tuj-1) (Roche) diluted (1:500) in the blocking solution with 5% normal goat
serum. Sections were incubated with a biotinylated secondary antibody (dilution,
1:200; Vector Labs) for an hour, and positive signals were developed with a
diaminobenzidine substrate by using the avidin-biotin-peroxidase system accord-
ing to the manufacturer’s instructions (Vector Labs).
Whole-mount in situ hybridization was performed essentially as previously
described (18). A partial Dyrk1A cDNA clone (nucleotides 241 to 590; accession
number U58497) was used as a template to generate sense and antisense ribo-
probes by in vitro transcription with the dioxigenin RNA labeling kit (Roche) by
using either T3 or T7 RNA polymerase.
Histology and immunohistochemistry of the nervous system. Adult and PD14
(postnatal day 14) mice were anesthetized and transcardially perfused with 4%
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. Brains were removed and
postfixed in the same buffer for 24 h at 4°C. Thereafter, they were cryoprotected
in 30% sucrose, frozen on dry ice, and sectioned on a cryostat. Serial coronal or
sagittal (30- or 50-m-thick) sections were collected in a cryoprotectant solution
(30% glycerol, 30% ethylene glycol, 40% 0.1 M phosphate buffer [pH 7.4]), and
every sixth section was stained with Nissl. Immunohistochemistry was performed
for two to five adult or PD14 male mice per genotype as described above (embryo
histology). Primary polyclonal antibodies from rabbits were against calbindin
(1:10,000), calretinin (1:3,000), parvalbumin (1:5,000) (all from Swant Antibod-
ies), and the glial fibrillary acidic protein (GFAP) (1:2,000) (Dako). Primary
monoclonal antibodies from mice were against syntaxin 1 (1:100,000) (HPC.1;
Sigma), SNAP 25 (1:2,000) (SMI-81; Stenberger Antibodies), and synaptobrevin
(VAM-2) (1:100,000) (Cl.69.1; Synaptic Systems). The rat monoclonal antibody
against the myelin proteolipid protein (PLP) was kindly provided by Boris Zalc
(INSERM, Paris, France).
Morphometric analysis. Morphometric analysis was performed on three adult
male mice per group. After cryoprotection, brains were coronally sectioned
(thickness, 50 m) in a cryostat. For determination of the area of the neuronal
soma, profiles of Nissl-stained neurons in layer V of the somatosensory barrel
cortex (40 objective) and the stratum griseum superficiale (SGS) of the supe-
rior colliculus (SC) (60 objective) (100 to 120 neurons per animal for each
region) were traced with the aid of a camera lucida and the areas were calculated
by using the IMAT image analysis program (Scientific-Technical Services, Uni-
versity of Barcelona). For quantitative analysis, Nissl-stained sections were an-
alyzed by using a 60 objective and a millimetric eyepiece. Numbers of nuclei in
the somatosensory barrel cortex (layers II-III, IV, and V), the thalamus (ventral
posteroromedial [VPM]), and the SC (SGS and stratum opticum [SO]) were
counted. Counts were carried out in four to eight different visual fields (1 mm2)
in parallel sections for each animal group. All data were statistically analyzed by
using the Student t test.
Somatometric and neurobehavioral analysis. Mice used for behavioral anal-
ysis were derived from crosses between wild-type F1 females and Dyrk1A/ F1
males. Mice were reared under standard conditions on a 12-h light-dark cycle
(lights on at 0800 am), at 20 to 22°C and a relative humidity of 50 to 70%, with
food and water available ad libitum. The day of birth was considered PD1. After
the weaning period, at the age of 3 to 4 weeks, animals were housed as siblings,
separated according to sex.
A cohort of 11 Dyrk1A/ and 7 Dyrk1A/ mice were examined during the
preweaning period. Somatometry was performed daily (PD1 to PD20) by weigh-
ing the pups and measuring the body length, from the tip of the nose to the base
of the tail, and the length of the tail. The day of appearance of developmental
landmarks was recorded and used as the unit of analysis. Neurobehavioral
analysis included a battery of tests evaluating preweaning sensorial and motor
responses (12) that reflect the maturation of the CNS.
Adult mice (5 to 10 male and female mice per genotype) were weighed weekly
from the 4th to the 12th week of age. Postweaning neurobehavioral analysis was
performed with a cohort of 23 Dyrk1A/ and 15 Dyrk1A/ mice at the age of
3 months. The effect of genotype was evaluated on 35 separate behavioral
measurements recorded as part of the SHIRPA primary screen protocol (28),
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which provides a comprehensive behavioral profile for each animal. This proto-
col has been used for high-throughput analysis in a large-scale mouse mutagen-
esis project and assesses as many as 40 separate measurements for each animal.
Full details of the experimental procedures can be found on the website for the
Mouse Mutagenesis consortium partners (http://www.mgu.har.mrc.ac.uk/muta-
base/shirpa_1.html). Assessment of each animal began with observation of un-
disturbed behavior in a cylindrical clear Perspex viewing jar (height, 15 cm;
diameter, 11 cm). Mice were then transferred to an arena (55 by 33 cm) for
observation of motor behavior. This was followed by a sequence of manipulations
using tail suspension where measurements of visual acuity, grip strength, body
tone, and reflexes were recorded.
Data analysis. When no significant differences were detected between male
and female mice of each genotype, results were combined. Unless stated other-
wise, the significance of the effects was assessed by a one-way or multivariate
analysis of variance (ANOVA) with Bonferroni’s post hoc analysis test. Student’s
t test was used for comparisons between two groups. All analyses were performed
by using the statistical package SPSS for Windows, version 8.0.
RESULTS
Targeted disruption of the Dyrk1A gene in ES cells. We used
standard gene-targeting techniques to generate Dyrk1A-defi-
cient mice. A 3.2-kb genomic fragment containing exon 7 and
most of exon 8 of the mouse Dyrk1A gene was replaced with a
neomycin resistance (neo) gene by homologous recombination.
The sequence removed encodes 112 amino acids of Dyrk1A
and includes the bipartite nuclear localization signal, a short
consensus sequence rich in aspartate residues that is specu-
lated to regulate the kinase activity (5), and the first three
subdomains (I to III) of the catalytic domain, which are nec-
essary for ATP binding activity (17) (Fig. 1A and B). Three
correctly targeted Dyrk1A/ ES cell clones were detected by
Southern blot analysis using a Dyrk1A external probe and were
confirmed by using a neo probe (Fig. 1C). Two of these clones
gave rise to germ line transmission chimeras that were bred to
establish the F1 generation.
To evaluate whether the targeted mutation could result in a
new allele, cDNAs obtained from brain RNA of control and
Dyrk1A/ mice were PCR amplified with primers external to
the homology arms. Sequencing of the products obtained re-
vealed that the mutant allele generated a new Dyrk1A tran-
script (Fig. 1D). This transcript was the outcome of an aberrant
splicing event involving exons 6 and 9, leading to deletion of
the neo cassette and exon 8. Although a truncated protein of
111 amino acid residues could result from this transcript, no
such product was detected by Western blotting using an anti-
body against the amino terminus of Dyrk1A (data not shown).
This protein could be made at undetectable levels, but it would
be inactive.
Embryonic mortality of homozygous Dyrk1A/ mice. Het-
erozygous Dyrk1A/ mice of the F1 generation were under-
represented among weaned pups and were phenotypically dis-
tinguishable due to their small body size (discussed in detail
below). In spite of these differences, adult heterozygotes ap-
peared healthy and were intercrossed to produce homozygous
mice. Genotyping of 51 offspring of such crosses revealed no
live homozygous Dyrk1A/ pups, indicating the lethality of
the mutation in embryos.
Previous data had shown the expression pattern of Dyrk1A
from E13 onward by in situ hybridization, while the expression
of the gene had been revealed at E11.5 by Northern blotting
(32). To determine at which embryonic stage the homozygous
mutants die, we collected embryos from timed pregnant moth-
ers, starting at E9.5. The amniotic sac of each embryo was
genotyped by Southern blotting or PCR (Fig. 2A). The results
of this analysis revealed that Dyrk1A/ embryos died be-
tween E10.5 and E13.5, with only 20% surviving at E13.5
(Table 1).
Whole-mount in situ hybridization revealed the presence of
the Dyrk1A transcript in the neural tubes of wild-type E9.5
embryos (Fig. 2B). High expression was observed in the optic
vesicle and the ventral neural tube, particularly along the
rhombencephalon and spinal cord, while moderate expression
was detected in the telencephalic, diencephalic, and mesence-
phalic vesicles. Strong expression was also observed in the otic
vesicle and the branchial arches. No expression was observed
in the truncus arteriosus or the bulbus cordis of the developing
heart, although the transcript was detected in the wall of the
common atrial chamber. No signal was detected in homozy-
gous Dyrk1A/ embryos when the same antisense probe was
used. Western blot analysis of proteins derived from E10.5
embryonic tissues confirmed the absence of the Dyrk1A pro-
tein in null embryos and showed a reduction of protein levels
in heterozygotes (Fig. 2C).
To study the morphology of the nullizygous embryos, E9.5,
E10.5, and E11.5 litters were analyzed by cresyl violet staining
of sagittal sections. Dyrk1A/ embryos presented a signifi-
cant growth delay, with 1/3 to 1/2 size reduction compared to
wild-type littermates. The morphology of the heart, liver pri-
mordium, branchial arches, and brain vesicles showed a devel-
opmental structural delay (Fig. 2D). In contrast, heterozygous
embryos of the same litters presented no significant size re-
duction or other morphological alteration relative to controls
(data not shown). We next performed immunohistochemistry
using the anti--tubulin antibody, which specifically stains dif-
ferentiating neuronal cells. Immunostained cells were detected
in the neural tubes of E9.5 Dyrk1A/ embryos, and their
number and distribution increased at E10.5 and E11.5. A sim-
ilar spatiotemporal pattern was observed in Dyrk1A/ em-
bryos, although the immunostaining was significantly reduced
from that for controls. In fact, there was a reduction in the
number of immunoreactive postmitotic neurons (Fig. 2E), in-
dicating either a defect in neuroblast proliferation or a delay in
the maturation of the nervous systems of Dyrk1A/ embryos.
Reduced postnatal viability and smaller body size of
Dyrk1A/ mice. To evaluate the effect of Dyrk1A protein
reduction on heterozygous mice, we studied the progeny re-
sulting from female Dyrk1A/ and male Dyrk1A/ matings.
Of 638 pups recorded at the time of birth, only 451 (70%)
survived by the end of the preweaning period. The remaining
187 pups (29% of the live-born pups) died during the first 3
days of life. Genotype analysis of the surviving pups showed a
30% reduction in the number of Dyrk1A/ mice compared to
the expected Mendelian ratio. Therefore, we attribute the re-
duction of the expected number of Dyrk1A/ mice to neo-
natal lethality.
Dyrk1A/ mice that survived to adulthood appeared dis-
tinctly smaller than their wild-type littermates (Fig. 3A). They
presented a significant reduction in body weight (F  285.7, df
 25, and P  0.0001 by ANOVA) and length (F  133.4, df
 25, P  0.0001) during the entire preweaning period (Fig.
3B). The body weight curve was shifted to the right in a non-
parallel fashion, indicating a progressive increase in the weight
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FIG. 1. Targeted disruption of mouse Dyrk1A by homologous recombination. (A) Schematic diagram of the Dyrk1A protein. Positions of the
catalytic domain and other structural motifs are indicated (NLS, bipartite nuclear localization signal; DH box, consensus sequence rich in aspartate
residues; PEST, proline, glutamate, serine, and threonine region; His, histidine repeat; Ser/Thr, serine/threonine repeat; I to XI, subdomains of
the catalytic domain). Dashed rectangle indicates the amino acid sequence deleted by gene targeting. (B) Diagram showing the genomic structure
of the endogenous wild-type (WT) allele, the targeting vector, and the homologous recombinant (HR) allele. Arrows indicate the transcriptional
orientations of the neo gene and the thymidine kinase (tk) gene in the targeting vector. The 5 flanking probe used for Southern blotting and the
expected sizes of the restriction fragments after EcoRI digestion of genomic DNA are shown. P1, P2, and P3 indicate the locations of the primers
used for PCR analysis (Fig. 2A); P4 and P5 indicate the locations of the primers used for RT-PCR (panel D). (C) Southern blots of EcoRI-digested
DNA from the wild-type parental ES cell line and three recombinant clones (clones 13, 26, and 40) hybridized with the Dyrk1A probe and a neo
probe. (D) (Right) RT-PCR analysis of adult brain tissue with primers external to the targeting event (exons 5 and 9 in panel B) gave rise to a
unique product in wild type (/) tissue, whereas an additional, shorter product was generated in Dyrk1A heterozygous (/) tissue. The same
aberrant transcript was also observed in brain and embryonic tissues of all Dyrk1A/ mice examined. This resulted from aberrant splicing, which
led to the deletion of the neo cassette and exon 8 and the introduction of a new stop codon immediately downstream of the targeting event. (Left)
Diagram of this alternative transcript.
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FIG. 2. Growth retardation of Dyrk1A/ embryos. (A) Genotyping of wild-type (Dyrk1A/), heterozygous (Dyrk1A/), and homozygous
(Dyrk1A/) embryos by PCR analysis of DNA from embryonic yolk sac tissue. Locations of primers used for amplification of wild-type and
targeted alleles are shown in Fig. 1B. (B) Whole-mount in situ hybridization in Dyrk1A/ and Dyrk1A/ E9.5 embryos using a riboprobe
containing the deleted Dyrk1A sequence. The absence of signal in the Dyrk1A/ embryo and its significant size reduction compared to the
wild-type embryo can be appreciated. Bars, 1 mm. (C) Western blot analysis of equivalent amounts of protein extracts from Dyrk1A/,
Dyrk1A/, and Dyrk1A/ embryos with an anti-Dyrk1A specific antibody. The typical cluster of Dyrk1A bands around 90 kDa is shown.
(D) Sagittal sections of cresyl violet-stained Dyrk1A/ and Dyrk1A/ embryos at E10.5. The differences between control and homozygous
embryos in size and organ development, as well as in the proportions of the brain vesicles, can be appreciated. Bars, 1 mm. (E) (Left panels) Sagittal
sections of E10.5 Dyrk1A/ and Dyrk1A/ embryos stained with an anti--tubulin antibody (Tuj-1) show a significant decrease in immuno-
staining for the mutant embryo. Bars, 2 mm. (Right panels) Areas within squares in left panels are amplified, showing fewer immunopositive
postmitotic neurons in Dyrk1A/ embryos than in wild-type embryos. Bars, 200 m. Abbreviations: atr, common atrial chamber; ba, branchial
arch; D, diencephalon; h, heart (truncus arteriosus and bulbus cordis); M, mesencephalon; m, mesodermal tissue; NT, neural tube; op, optic
vesicle; ot, otic vesicle; Rh, rhombencephalon; T, telencephalon.
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difference between the two groups. In contrast, the body length
curve of Dyrk1A/ mice increased in parallel to that of their
wild-type littermates. After weaning, both male and female
Dyrk1A/ mice presented a sustained lower body weight,
with an average reduction of 30% (Fig. 3B and C).
To determine the effect of the mutation on organ size, we
systematically weighed representative organs from adult het-
erozygous and control littermates. Although the brain and
heart were lighter in Dyrk1A/ mice, these decreases were
proportional to the general decrease in body weight. On the
other hand, the cerebellum (including the posterior mesen-
cephalon) and liver presented disproportionate decreases in
weight (Fig. 3C). This suggests that although Dyrk1A is ubiq-
uitously expressed, the gene dose reduction influences the
growth of different organs and tissues differentially. Gross his-
tological examination of distinct organs revealed no obvious
morphological abnormalities (data not shown).
Reduced brain size but normal cytoarchitectonics in most
brain regions of Dyrk1A/ mice. The brains of adult
Dyrk1A/ mice were about 30% smaller than those of re-
spective wild-type mice and presented a remarkable macro-
scopic reduction in the mesencephalic tectum, which is com-
posed of the superior and inferior colliculi (Fig. 4A). The rest
of the brain regions were also decreased, although not in a
homogeneous fashion. Nissl-stained sagittal sections revealed
pronounced reductions in the midbrains and hindbrains of
Dyrk1A/ mice compared to forebrain structures such as the
FIG. 3. Growth retardation and body size reduction of Dyrk1A/ mice. (A) Comparison between a 1-month-old male wild-type mouse (/)
and a heterozygous (/) littermate indicates the significant body reduction of the Dyrk1A/ mouse. (B) Somatometric curves of preweaning
mice. (Top) Weight gain retardation of Dyrk1A/ mice early in life. Dyrk1A/ mice remained underweight throughout life in comparison to
their wild-type siblings. (Bottom) Growth retardation during early life in Dyrk1A/ mice. Each data point represents a mean 	 standard
deviation. Data points for adult weights represent means of male weights. *, P  0.001 by repeated-measures ANOVA; for all other data points,
P  0.0001 by repeated-measures ANOVA. (C) Percent decreases in body and organ weights in 3-month-old male Dyrk1A/ mice relative to
those of age-matched Dyrk1A/ littermates. Asterisks indicate significant decreases in the body or net organ weight of Dyrk1A/ mice (n  4
mice per group; *, P  0.05 by Student’s t test; **, P  0.005 by Student’s t test). Abbreviations: wt, weight; Foreb, forebrain; Hindb, hindbrain
and posterior part of mesencephalon.
TABLE 1. Genotypes of embryos from Dyrk1A/ matings
Day of
gestation
No. of
embryos
% Embryos % Dead /
embryos/ / /
9.5 39 13 61 26 0
10.5 93 29 50 21 20
11.5 143 27 53 20 45
12.5 36 31 44 25 67
13.5 12 33 25 42 80
14.5 6 17 83 0 100
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FIG. 4. Histological characterization of Dyrk1A/ brains. (A) Dorsal views of brains of wild type (/) and Dyrk1A heterozygous (/)
adult mice. Arrows point to the mesencephalic tectum, which is particularly decreased in/ brains. Bars, 2 mm. (B) Nissl-stained sagittal sections
of / and / brains. Abbreviations: cx, cerebral cortex; H, hippocampus; Hy, hypothalamus; ic, inferior colliculus; Mo, medulla oblongata; ob,
olfactory bulb; P, pons; sc, superior colliculus; sp, septum; st, striatum; T, thalamus; Tg, tegmentum. Bars, 2 mm. (C) Coronal sections of the
medulla oblongata stained with Nissl. A significant decrease is observed in the Dyrk1A/ section, although all nuclei (10, dorsal motor; 12,
hypoglossal; Gi, gigantocellular reticular; IO, inferior olive; LRt, lateral reticular) are present. Bars, 500 m. (D) Nissl-stained sagittal sections of
/ and / cerebella. The layers and folia of the Dyrk1A/ cerebellum are found normal. Bars, 500 m. (E) Coronal sections of parvalbumin-
immunostained brains reveal normal lamination of the Dyrk1A/ cerebral cortex and hippocampus. Bars, 300 m. (F) GFAP immunostaining
in PD14 coronal brain sections shows increased GFAP immunoreactivity in Dyrk1A/ mice. 4V, 4th ventricle. Bars, 75 m.
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cerebral cortex and olfactory bulb (Fig. 4B). This is in accor-
dance with the disproportionate reduction in weight of these
brain regions (Fig. 3C). Furthermore, ventral brain regions,
including the hypothalamus, pons, and medulla oblongata,
were more severely affected than dorsal structures, such as the
cerebellum or the neocortex (Fig. 4B, C, and D). These obser-
vations indicate a region-specific action of the mutation.
In spite of the differences in size, no obvious malformations
were observed in the lamination of the olfactory bulb, neocor-
tex, hippocampus, and cerebellar cortex (Fig. 4D) or in the
structure of the striatum, thalamus, hypothalamus, and brain
stem. Staining with antibodies against the major synaptic pro-
teins SNAP 25, syntaxin 1, and synaptobrevin revealed that
neither the expression of these proteins in the plexiform layers
nor in the major axonal pathways were apparently altered in
the brains of Dyrk1A/ mice (data not shown). Immunostain-
ing for the calcium-binding proteins calbindin D-28K, parval-
bumin, and calretinin, which are used as markers for study of
the CNS, showed that most neuronal subpopulations in
Dyrk1A/ mice exhibited normal distributions and immuno-
reactivities. For instance, Fig. 4E shows no difference between
control and Dyrk1A/ brains in the pattern of parvalbumin
immunostaining in the cerebral cortex and hippocampus.
To evaluate a possible effect of Dyrk1A on the maturation of
the CNS, similar immunohistochemical analyses were per-
formed at PD14, an age at which a marked decrease in cortical
calbindin D-28K-positive interneurons coincides with the
emergence of parvalbumin immunoreactivity (1, 2). Again, the
intensity and distribution of these neural markers were not
altered in Dyrk1A/ mice (data not shown). These findings
reveal that although the brains of Dyrk1A/ mice are reduced
in size, most of the brain regions show normal cytoarchitec-
tonics and neuronal components.
The macroglial cell populations of PD14 and adult brains
were examined with antibodies against GFAP, an astroglial
marker, and PLP, a marker of myelinated oligodendrocytes.
Whereas GFAP staining was increased in all regions of both
PD14 (Fig. 4F) and adult Dyrk1A/ brains, no differences in
A
B
SGS
SO
SGI
+/-SGS
SO
+/+
SGI
SGS and SO
SGI
+/+
SGI
SGS and SO+/-
FIG. 5. Alterations in the mesencephalic tectum of Dyrk1A/ mice. Shown are coronal sections of the SC of wild type (/) and Dyrk1A
heterozygous (/) adult mice immunostained with calbindin (A) or calretinin (B). Dashed lines mark the thickness of the SGS and SO. The size
reductions of these superficial layers in Dyrk1A/ mice can be appreciated. SGI, stratum griseum intermedium. Bars, 100 m.
TABLE 2. Neuronal counts from Dyrk1A/ and Dyrk1A/
brain regions
Region
Neuronal counta (mean 	 SD)
Pb
Dyrk1A/ Dyrk1A/
Cortical layers II–III 200.5 	 11.6 262.8 	 34.5  0.0005
Cortical layer IV 243.7 	 34.5 312.2 	 66.4 0.015
Cortical layer V 114.8 	 14.5 152.4 	 11.6  0.0005
Thalamic VMP 133.3 	 16.2 153.7 	 8.3 0.03
SC
SGS 268.5 	 20.7 277.1 	 24.3 0.46
SO 223.3 	 45.9 252.3 	 23.7 0.20
a Mean number of neurons per 106 m2 from four to eight different visual
fields (50 m thick) for each group.
b By Student’s t test.
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the pattern of PLP immunoreactivity between mutant and con-
trol brains were observed.
To evaluate possible alterations in cell body sizes that may
account for the size reduction of Dyrk1A/ brains, the areas
of Nissl-stained neurons were measured in the neocortex, a
brain region that presented moderate reduction, and the SC of
the mesencephalic tectum, which presented severe reduction.
No differences were observed between control and Dyrk1A/
brains either in the pyramidal cells and the interneurons of
layer V of the somatosensory barrel cortex (130.1 	 54.8 m2
in Dyrk1A/ mice versus 133.3 	 53.5 m2 in controls; P 
0.426) or in neurons of the SGS of the SC (58.8 	 23.5 m2 in
Dyrk1A/ mice versus 62.6 	 24.2 m2 in controls; P  0.1).
Next, the densities of neuronal cells from different brain re-
gions of control and Dyrk1A/ mice were calculated. Neuro-
nal densities in different layers of the somatosensory cortex
and in the thalamic VPM nucleus were found to be signifi-
cantly greater for Dyrk1A/ mice than for controls (Table 2).
This result indicates that the reduced size of these brain re-
gions may be due to a decrease in the neuropil rather than to
neuronal loss. In contrast, the neural densities of the SGS and
the SO of the SC did not present significant differences be-
tween control and Dyrk1A/ brains (Table 2). Immunostain-
ing for the calcium-binding proteins revealed the presence of
all major neuronal components of the SC. Nevertheless, stain-
ing with calbindin showed clearly that the sizes of SC superfi-
cial layers (SGS and SO) were severely reduced in Dyrk1A/
brains (Fig. 5A). In addition, the density of calretinin-immu-
noreactive fibers, which are known to label retinofugal axons
(14), was markedly decreased in the SGC and SO layers of
Dyrk1A/ brains (Fig. 5B). These results indicate that the
reduced size of the SC is due to a reduction in the total number
of neurons present in this region as well as to a decreased
number of afferent fibers.
Neurobehavioral abnormalities of Dyrk1A/ mice. The
fact that DYRK1A may be involved in neurogenesis and may
subsequently affect neurodevelopmental processes prompted
us to analyze the neurobehavioral development of Dyrk1A/
mice. Compared to their control littermates, these mice
showed a significant delay in eyelid (PD 16.3 	 0.28 versus PD
13.4 	 0.16 in controls; t  9.39 and P  0.0001 by Student’s
t test) and ear (PD 15.6	 0.20 versus PD 13.6	 0.16; t 7.64;
P  0.0001) opening. Examination of sensorial and motor
reflexes revealed a significant delay in the appearance of the
righting reflex in heterozygotes (PD 5.8 	 1.01 versus PD 2.1
	 0.35; t  4.03; P  0.001). This reflex evaluates the ability of
the animal to turn from a supine to a prone position, and its
acquisition depends on both muscular strength and neuromo-
tor development. Chi-square analysis did not reveal any cor-
relation between body weight and day of appearance of the
righting reflex, thus excluding the reduced body weight of
Dyrk1A/ mice as a cause for the delay. A delay was also
observed in the appearance of Preyer’s reflex, an acoustically
triggered reflex (PD 16.1 	 0.26 versus PD 13.8 	 0.13; t 
8.72; P  0.0001), probably as a functional consequence of the
FIG. 6. Preweaning neurobehavioral analysis. Bars represent mean PDs for the emergence of physical landmarks or the achievement of mature
responses in reflexological and behavioral tasks. **, P  0.001 by Student’s t test; ***, P  0.0001 by Student’s t test. Error bars, standard errors.
Inf, inferior.
TABLE 3. SHIRPA primary behavioral assessment of adult
Dyrk1A/ mice
Testa
Score (mean)
Significanceb
Dyrk1A/ Dyrk1A/
Body position 3.2 3.0 NS
Spontaneous activity 1.8 1.7 NS
Negative geotaxis 0.4 0.6 NS
Toe pinch 2.1 1.9 NS
Corneal reflex 1.5 2.1 NS
Visual placing 2.6 2.4 NS
Fear 1.0 1.0 NS
Irritability 0.8 0.6 NS
Freezing 1.3 1.8 P  0.05
Startle response 3.0 2.4 P  0.03
a Only tests relevant to the model are shown.
b By Student’s t test. NS, not significant.
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retarded ear opening of Dyrk1A/ mice. Maturation of other
neurological reflexes did not present any differences between
the two groups (Fig. 6).
To assess neurobehavioral differences between Dyrk1A/
and Dyrk1A/ mice in adulthood, quantitative data about the
performance of each individual were obtained from the pri-
mary screen of the SHIRPA protocol (28). Dyrk1A/ mice
were normal in most of the tests, but they presented prolonged
freezing behavior compared to controls (score, 1.8 	 0.13
versus 1.3 	 0.24 in controls; t -2.0; P  0.05). The startle
response was reduced in Dyrk1A/ mice (score, 2.4 	 0.23
versus 3.0 	 0.01; t  2.55; P  0.03), while the visual placing
test, which evaluates gross visual defects, was found normal.
There was no significant effect of genotype on performance in
tests measuring neuromuscular function, such as grip strength,
limb tone, and wire maneuver, or in other sensory tests (tactile,
proprioceptive, and nociceptive) (Table 3). These results sug-
gest that the dose reduction of Dyrk1A causes specific neuro-
logical alterations.
DISCUSSION
Dyrk1A belongs to a novel subfamily of protein kinases
(DYRKs) with unique structural and enzymatic features. In
this study, we report the generation of a gene-targeting model
for Dyrk1A and describe the phenotypic consequences of the
loss of one and two copies of the gene.
Homozygous Dyrk1A/ mice died during the period of
organogenesis, between E10.5 and E13.5. Null embryos pre-
sented growth retardation, with reduction in body size and
morphological developmental delay of the primitive organs, at
the stages immediately prior to their deaths (E9.5 to E11.5).
Many reported lethal mutants that die during this period
present growth retardation defects, whereas for most, the
cause of death is unknown. In general, the major developmen-
tal abnormalities that lead to death around the period of or-
ganogenesis include defective yolk sac circulation and failure
to establish a chorioallantoic placenta, both leading to poor
embryonic blood circulation (9). For the Dyrk1A/embryos,
the pale color of the yolk sac in most cases, as well as a swelling
of the pericardium observed in some cases, suggests that de-
fects in yolk sac hematopoiesis could be responsible for death.
The strong expression of Dyrk1A in the neural tube and the
otic vesicle at E9.5, revealed by in situ hybridization analysis,
suggests an important role for this gene during early stages of
mouse nervous system development. The significant decrease
in the number of postmitotic neural cells in Dyrk1A/ em-
bryos, revealed by -tubulin immunostaining, is in accordance
with the general developmental delay of the null embryos.
However, the possibility that the loss of Dyrk1A could lead to
a nervous system defect, related either to a reduction in the
number of neuroblasts or to a deregulation of neural differen-
tiation, should also be considered.
Newborn heterozygotes showed reduced neonatal viability
and a decrease in the body size of surviving mice, while het-
erozygous embryos at E9.5 to E11.5 presented normal gross
morphology. This suggests that although the reduction in
Dyrk1A protein amounts is not sufficient to limit viability and
growth during the period of organogenesis, Dyrk1A is critical
for normal growth of the pups. The observation of growth
delay as early as PD1 indicates that it arises from an intrinsic
intrauterine retardation during the last stages of gestation,
when rodent Dyrk1A is highly expressed (27). The increased
difference in weight between Dyrk1A/ pups and their wild-
type counterparts during the last week of the preweaning pe-
riod suggests that the growth delay might be dependent not
only on intrinsic genetic factors but also on a poorer adaptive
response. This growth defect affects both sexes similarly and is
not overcome in adulthood. Interestingly, a similar size reduc-
tion has been described for adult mnb flies (34).
During the preweaning period, when essential processes of
brain regionalization and acquisition of functional competence
are taking place, fundamental sensory-motor abilities are ac-
quired. Among the different reflexes that determine motor
coordination and balance (righting reflex, negative geotaxis,
and cliff aversion), a significant delay was observed only in the
appearance of the righting reflex in Dyrk1A/ pups. All of
these reflexes depend mainly on the cerebellovestibular system
and arise at different time points during the preweaning period
(23). The appearance of the righting reflex coincides with en-
hanced expression of rodent Dyrk1A in the cerebellum ob-
served when important developmental processes are taking
place (27), and this could account for the specific delay of this
reflex produced by Dyrk1A dose reduction. Again, the devel-
opmental delay of Dyrk1A/ mice presents an analogy to the
longer time that mnb flies need for development (34).
During adulthood, Dyrk1A/ mice exhibit normal sponta-
neous behavior in general, as revealed by the SHIRPA primary
analysis. The enhanced freezing response suggests increased
anxiety or, alternatively, changes in the emotional behavior of
Dyrk1A/ mice. On the other hand, the poorer reactivity of
Dyrk1A/ mice, shown by the lower score on Preyer’s reflex,
indicates an acoustic deficit, which might be related to the
retarded appearance of this reflex during the preweaning pe-
riod. Thus, the Dyrk1A dose reduction does not result in gross
neurological defects but rather in subtle alterations that may
involve specific CNS functional domains.
Human DYRK1A has been proposed as a candidate gene for
some of the neurological defects observed in DS patients. This
notion has been supported by its mapping position in the DS
critical region, its ubiquitous expression in the adult and em-
bryonic nervous systems (16, 27, 29, 32), its overexpression in
the brains of DS patients (15), and the neurobehavioral alter-
ations shown by transgenic mice overexpressing the gene (3,
30). Taken together, these data indicate the involvement of
DYRK1A in CNS function. Nevertheless, the only morpholog-
ical evidence about its essential role in the CNS so far comes
from Drosophila mutants with reduced mnb expression, result-
ing in flies with small brain size (34). A remarkable effect of
mouse Dyrk1A haploinsufficiency was a disproportionate brain
reduction, providing strong evidence about the functional im-
portance of the gene in the development of the mammalian
CNS. The prominent decreases in the posteroventral brains of
adult Dyrk1A/ mice coincide with high-level expression of
Dyrk1A during early embryonic development in the posterov-
entral neural tube (rhombencephalon and spinal cord). The
normal histological patterns of the brain structures of
Dyrk1A/ mice, together with a disproportionate reduction
in specific areas, are analogous to the lack of significant archi-
tectural abnormalities and to the presence of region-specific
VOL. 22, 2002 DEVELOPMENTAL AND CNS CHANGES IN Dyrk1A MUTANT MICE 6645
brain reductions in mnb flies, respectively (34). Interestingly, a
functional analogy exists between two structures that are found
disproportionately reduced in the mouse and fly mutants. The
SC presents a horizontal laminated organization and is a major
target of retinal ganglion cells, while the optic lobe is a three-
layered structure that receives the input of the photoreceptor
cells of the Drosophila ommatidia (10). Therefore, the high
degree of phenotypic resemblance between Dyrk1A/ and
mnb mutants suggests a conserved role of the DYRK1A kinase
in the function of the nervous system.
The significant increases in the cell densities of the somato-
sensory cortex and thalamus of the Dyrk1A/ brain suggest a
tighter arrangement of neuronal cells. This could result either
from reductions in neurite complexity and in the size of the
soma or from a decrease in the surrounding glia. No differ-
ences in the area of the soma were revealed between the two
groups, while there was an increase in the number of GFAP-
positive cells in Dyrk1A/ brains, indicating an increase in
the astroglial population. The recent finding that overexpres-
sion of a kinase-deficient DYRK1A attenuates the neurite
outgrowth of hippocampal cells after bFGF stimulation (37)
indicates that Dyrk1A dose reduction could affect the length
and complexity of the neuropil. Thus, we propose that the
decreases in the sizes of the somatosensory cortex and thala-
mus of the Dyrk1A/ brain are outcomes of the crowding of
neuronal cells, probably due to a decrease in the arborization
of the neuropil.
In contrast to the above observations, the densities of the
neuronal populations in the SGS and the SO of the SC were
found unchanged, indicating that the remarkable reductions in
the sizes of these layers in Dyrk1A/ brains may result from
a reduction in neuronal cell numbers. In addition, immuno-
staining with calretinin revealed a significant reduction in the
number of retinal cell afferents of the SGS and SO layers,
suggesting decreased fiber number as an additional cause for
the reductions in the sizes of these layers. We and others (32)
have observed high Dyrk1A expression in the optic vesicle
during embryonic development, suggesting that the dose re-
duction of the Dyrk1A gene could cause a specific defect in the
developing retina. In contrast, Dyrk1A is moderately expressed
in the dorsal mesencephalic vesicle, from which the mesence-
phalic tectum will derive. Considering these data, we suggest
that reductions in Dyrk1A protein levels lead to reductions in
the numbers of retinofugal fibers in the SGS and the SO layers
of Dyrk1A/ brains and to subsequent decreases in the num-
bers of neurons in these layers.
Minimal deletions in the region where human DYRK1A
maps have been described in partial monosomy 21 (MO-21)
patients (24), who present microcephaly, mental retardation,
intrauterine and postnatal growth retardation, and character-
istic physical features (8). Dyrk1A/ mice present reductions
in brain size, possible intrauterine growth retardation, and
postnatal growth retardation, resulting from targeted deletion
of one allele. The striking phenotypic similarities between
Dyrk1A/ mice and MO-21 patients suggest that some of the
characteristic features of MO-21 could be directly related to
the dose reduction of DYRK1A and that Dyrk1A/ mice
should be considered as a possible mouse model for the study
of microcephaly.
In conclusion, the mortality of Dyrk1A/ embryos and the
alterations in Dyrk1A/ mice support the vital, nonredundant
role of Dyrk1A. The phenotype of Dyrk1A/ provides evi-
dence about the role of Dyrk1A in cellular mechanisms that
determine body growth and development. In the CNS, Dyrk1A
is involved in the determination of the size of the brain, prob-
ably through mechanisms that control neural differentiation.
The notable resemblance of the effects of its loss in the
Dyrk1A/ mouse to those in the mnb mutant fly suggests a
conserved function, emphasizing its biological importance
along the phylogenetic tree.
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